These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 30286225

  • 21. Lichenoid eruption associated with antituberculous drug; an unusual oral and follicular involvement.
    Byun JW, Bang CY, Choi GS, Shin J.
    Am J Dermatopathol; 2014 Aug; 36(8):684-5. PubMed ID: 23823026
    [No Abstract] [Full Text] [Related]

  • 22. Tracheoesophageal Fistula Caused by Successful Response to Pembrolizumab in a Patient With Squamous Cell Lung Cancer.
    Wang H, Zhang L, Liu W.
    J Thorac Oncol; 2019 Jul; 14(7):e141-e143. PubMed ID: 31235036
    [No Abstract] [Full Text] [Related]

  • 23. Lichenoid drug eruption after treatment with ixekizumab for plaque psoriasis.
    Ghiam N, Ojong O, Vasile G, Romanelli P, Kerdel F.
    Dermatol Online J; 2020 Dec 15; 26(12):. PubMed ID: 33423430
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
    Siegel J, Totonchy M, Damsky W, Berk-Krauss J, Castiglione F, Sznol M, Petrylak DP, Fischbach N, Goldberg SB, Decker RH, Stamatouli AM, Hafez N, Glusac EJ, Tomayko MM, Leventhal JS.
    J Am Acad Dermatol; 2018 Dec 15; 79(6):1081-1088. PubMed ID: 30025829
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Real-World Experience With Pembrolizumab in Patients With Advanced Lung Cancer.
    Peng TR, Wu TW.
    Am J Ther; 2019 Dec 15; 26(4):e537-e538. PubMed ID: 30946046
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. An unknown reaction to pembrolizumab: giant cell arteritis.
    Micaily I, Chernoff M.
    Ann Oncol; 2017 Oct 01; 28(10):2621-2622. PubMed ID: 28633343
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after programmed cell death 1 inhibition with nivolumab.
    Feldstein SI, Patel F, Larsen L, Kim E, Hwang S, Fung MA.
    J Eur Acad Dermatol Venereol; 2018 Feb 01; 32(2):e58-e59. PubMed ID: 28776778
    [No Abstract] [Full Text] [Related]

  • 32. Nivolumab-induced lichenoid penile ulceration and re-emergent mucocutaneous eruption treated with hydroxychloroquine.
    Headd VA, Mathien A, Pei S, Kuraitis D.
    Australas J Dermatol; 2024 Jun 01; 65(4):e97-e99. PubMed ID: 38337182
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Susac's syndrome as an immune-related adverse event after pembrolizumab: a case report.
    De Groot M, Compter A, De Langen AJ, Brandsma D.
    J Neurol; 2020 Jan 01; 267(1):282-284. PubMed ID: 31701330
    [No Abstract] [Full Text] [Related]

  • 35. Ipilimumab-associated halo-like inflammatory reactions around nevi during therapy for metastatic melanoma.
    Alniemi DT, Fischer A, Greene LA, Pierson JC.
    Dermatol Online J; 2018 Jul 15; 24(7):. PubMed ID: 30261564
    [Abstract] [Full Text] [Related]

  • 36. Immune Checkpoint Inhibitor-Associated Central Adrenal Insufficiency.
    Mishra T, He G, Sreeram K, Rauf M, Subahi A, Hazem M.
    Am J Ther; 2019 Jul 15; 26(5):e626-e627. PubMed ID: 30277909
    [No Abstract] [Full Text] [Related]

  • 37. Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect.
    Garcovich S, Burlando M, Rongioletti F, Garcovich A, Parodi A, Amerio P.
    Acta Derm Venereol; 2010 May 15; 90(3):311-2. PubMed ID: 20526559
    [No Abstract] [Full Text] [Related]

  • 38. Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature.
    Cosimati A, Rossi L, Didona D, Forcella C, Didona B.
    J Oncol Pharm Pract; 2021 Apr 15; 27(3):727-733. PubMed ID: 32772795
    [Abstract] [Full Text] [Related]

  • 39. Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature.
    Kuraishi N, Nagai Y, Hasegawa M, Ishikawa O.
    Acta Derm Venereol; 2010 Apr 15; 90(1):73-6. PubMed ID: 20107730
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.